指南与共识神经肿瘤脊柱脊髓外科

脊柱转移瘤再程放疗的脊柱立体定向体部放疗:系统综述

Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review.
指南 / 共识 · J Neurosurg Spine · 2017-07-14

本文系统综述了脊柱立体定向体部放疗(SBRT)用于既往已照射脊柱转移瘤的疗效与安全性。检索2263篇文献后纳入9项研究,均为单机构系列(低或极低质量数据)。结果显示中位1年局部控制率76%(范围66%-90%),疼痛评分改善65%-81%,椎体骨折粗发生率12%(范围0%-22%),放射性脊髓病1.2%。作者认为SBRT对再程放疗安全有效,可作为推荐治疗选择。

要点

  • 再程脊柱SBRT的中位1年局部控制率为76%(范围66%-90%)。
  • SBRT后疼痛评分改善范围为65%至81%。
  • 椎体骨折粗发生率为12%(范围0%-22%),放射性脊髓病为1.2%。

核心结论

  • 该系统综述提示,对既往已照射的脊柱转移瘤行SBRT在局部控制和疼痛缓解方面安全有效。
  • 尽管证据限于低质量数据,SBRT可作为再程放疗的推荐治疗选择。

研究设计与样本

  • 系统文献综述,检索MEDLINE、Embase、Cochrane循证医学数据库、National Guideline Clearinghouse和CMA Infobase,并补充文献书目复习,针对脊柱SBRT。
  • 初始检索获得2263篇文献,160篇可能相关,105篇进入深入审查,最终9项研究符合全部纳入标准。
  • 9项研究均为单机构系列,包括4项回顾性研究、3项基于前瞻性数据库的回顾性系列、1项前瞻性研究和1项I/II期前瞻性研究(低或极低质量数据)。

主要发现

  • 脊柱SBRT有效,中位1年局部控制率为76%(范围66%-90%)。
  • SBRT后患者疼痛评分改善范围为65%至81%。
  • 治疗实施安全,椎体骨折粗发生率为12%(范围0%-22%),放射性脊髓病为1.2%。

临床怎么用

  • 作者认为,对既往已照射的脊柱转移瘤,SBRT可作为再程放疗的推荐治疗选择。

局限性

  • 所有纳入研究均为单机构系列。
  • 证据限于低或极低质量数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE Spinal metastases that recur after conventional palliative radiotherapy have historically been difficult to manage due to concerns of spinal cord toxicity in the retreatment setting. Spine stereotactic body radiation therapy (SBRT), also known as stereotactic radiosurgery, is emerging as an effective and safe means of delivering ablative doses to these recurrent tumors. The authors performed a systematic review of the literature to determine the clinical efficacy and safety of spine SBRT specific to previously irradiated spinal metastases. METHODS A systematic literature review was conducted, which was specific to SBRT to the spine, using MEDLINE, Embase, Cochrane Evidence-Based Medicine Database, National Guideline Clearinghouse, and CMA Infobase, with further bibliographic review of appropriate articles. Research questions included: 1) Is retreatment spine SBRT efficacious with respect to local control and symptom control? 2) Is retreatment spine SBRT safe? RESULTS The initial literature search retrieved 2263 articles. Of these articles, 160 were potentially relevant, 105 were selected for in-depth review, and 9 studies met all inclusion criteria for analysis. All studies were single-institution series, including 4 retrospective, 3 retrospective series of prospective databases, 1 prospective, and 1 Phase I/II prospective study (low- or very low-quality data). The results indicated that spine SBRT is effective, with a median 1-year local control rate of 76% (range 66%-90%). Improvement in patients' pain scores post-SBRT ranged from 65% to 81%. Treatment delivery was safe, with crude rates of vertebral body fracture of 12% (range 0%-22%) and radiation-induced myelopathy of 1.2%. CONCLUSIONS This systematic literature review suggests that SBRT to previously irradiated spinal metastases is safe and effective with respect to both local control and pain relief. Although the evidence is limited to low-quality data, SBRT can be a recommended treatment option for reirradiation.

来源:J Neurosurg Spine,查看原文。版权归原作者所有。

引用

  1. Myrehaug S, Sahgal A, Hayashi M, et al. Reirradiation spine stereotactic body radiation therapy for spinal metastases: systematic review. J Neurosurg Spine. 2017. PMID: 28708043. doi:10.3171/2017.2.SPINE16976

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。